Okay, let's tackle this question about lidocaine. The question is asking which statement is not true about lidocaine. First, I need to recall the key properties of lidocaine. It's a local anesthetic and antiarrhythmic drug, right? It works by blocking sodium channels, so it's in class IB. That's important for the antiarrhythmic mechanism.

The core concept here is the pharmacology of lidocaine. I need to remember its uses, mechanisms, and how it compares to other drugs. Let's think about the options. Since the user didn't provide the options, I'll have to imagine common ones. Common false statements might involve its use in certain conditions, side effects, or metabolism.

For example, a common mistake is thinking lidocaine is used for treating ventricular arrhythmias via a different class. But lidocaine is class IB, so if an option said it's class IC, that's wrong. Another point is its metabolism—lidocaine is metabolized in the liver by CYP enzymes, so if an option said it's excreted unchanged in urine, that's incorrect.

The correct answer would be the one that contradicts these facts. Let's say the options included something like "Lidocaine is effective in supraventricular arrhythmias." That's false because it's mainly for ventricular. Or maybe "Lidocaine has a rapid onset when given intravenously," which is true, so that would be a correct statement.

I need to explain why the correct answer is wrong. For instance, if the question is asking for the false statement, and one option says it's used for supraventricular arrhythmias, I need to clarify that lidocaine is actually used for ventricular. Also, its mechanism of action and metabolism should be discussed.

The clinical pearl here is to remember that lidocaine is class IB, short-acting, and used for ventricular arrhythmias, not supraventricular. Also, it's metabolized in the liver, so hepatic impairment affects its use.

Putting this all together, the explanation should cover the core concept, why the correct answer is false, and why the others are true. I need to make sure each section is concise and sticks to the required structure.

**Core Concept**
Lidocaine is a class IB antiarrhythmic and local anesthetic that blocks voltage-gated sodium channels. It preferentially acts on abnormal cardiac tissue and is used for ventricular arrhythmias. Its pharmacokinetics include rapid hepatic metabolism via CYP enzymes.

**Why the Correct Answer is Right**
The false statement is likely related to lidocaine's use in supraventricular arrhythmias. Lidocaine has minimal efficacy in supraventricular tachyarrhythmias because it spares the AV node and Purkinje fibers. Its primary role is in ventricular arrhythmias (e.g., post-MI, digitalis toxicity), where it shortens the action potential duration and reduces automaticity.

**Why Each Wrong Option is Incorrect**
**Option A:** If claiming lidocaine is a class IB antiarrhythmic, this is correct (e.g., mexiletine is class IB; lidocaine fits this classification).
**Option B:** If stating lidocaine

✓ Correct Answer: C. Ester